BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25351474)

  • 1. The effect of the novel phosphodiesterase-4 inhibitor MEM 1414 on the allergen induced responses in mild asthma.
    Leaker BR; Singh D; Ali FY; Barnes PJ; O'Connor B
    BMC Pulm Med; 2014 Oct; 14():166. PubMed ID: 25351474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild-to-moderate asthma.
    Leaker BR; Barnes PJ; O'Connor BJ; Ali FY; Tam P; Neville J; Mackenzie LF; MacRury T
    Clin Exp Allergy; 2014 Sep; 44(9):1146-53. PubMed ID: 25040039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial.
    Beeh KM; Beier J; Meyer M; Buhl R; Zahlten R; Wolff G
    Pulm Pharmacol Ther; 2006; 19(4):233-41. PubMed ID: 16140027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo.
    Diamant Z; Timmers MC; van der Veen H; Friedman BS; De Smet M; Depré M; Hilliard D; Bel EH; Sterk PJ
    J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):42-51. PubMed ID: 7822663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma.
    Singh D; Petavy F; Macdonald AJ; Lazaar AL; O'Connor BJ
    Respir Res; 2010 Mar; 11(1):26. PubMed ID: 20193079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma.
    Evans DJ; Barnes PJ; Spaethe SM; van Alstyne EL; Mitchell MI; O'Connor BJ
    Thorax; 1996 Dec; 51(12):1178-84. PubMed ID: 8994512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of JNJ-40929837, a leukotriene A4 hydrolase inhibitor, in a bronchial allergen challenge model of asthma.
    Barchuk W; Lambert J; Fuhr R; Jiang JZ; Bertelsen K; Fourie A; Liu X; Silkoff PE; Barnathan ES; Thurmond R
    Pulm Pharmacol Ther; 2014 Oct; 29(1):15-23. PubMed ID: 25018015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a novel orally active selective PDE4 isoenzyme inhibitor (CDP840) on allergen-induced responses in asthmatic subjects.
    Harbinson PL; MacLeod D; Hawksworth R; O'Toole S; Sullivan PJ; Heath P; Kilfeather S; Page CP; Costello J; Holgate ST; Lee TH
    Eur Respir J; 1997 May; 10(5):1008-14. PubMed ID: 9163639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with a peroxisomal proliferator activated receptor gamma agonist has a modest effect in the allergen challenge model in asthma: a randomised controlled trial.
    Richards DB; Bareille P; Lindo EL; Quinn D; Farrow SN
    Respir Med; 2010 May; 104(5):668-74. PubMed ID: 19944580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics.
    Diamant Z; Sidharta PN; Singh D; O'Connor BJ; Zuiker R; Leaker BR; Silkey M; Dingemanse J
    Clin Exp Allergy; 2014 Aug; 44(8):1044-52. PubMed ID: 24964348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma.
    Singh D; Richards D; Knowles RG; Schwartz S; Woodcock A; Langley S; O'Connor BJ
    Am J Respir Crit Care Med; 2007 Nov; 176(10):988-93. PubMed ID: 17717202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
    Norris V; Choong L; Tran D; Corden Z; Boyce M; Arshad H; Holgate S; O'Connor B; Millet S; Miller B; Rohatagi S; Kirkesseli S
    J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects.
    Gauvreau GM; Boulet LP; Schmid-Wirlitsch C; Côté J; Duong M; Killian KJ; Milot J; Deschesnes F; Strinich T; Watson RM; Bredenbröker D; O'Byrne PM
    Respir Res; 2011 Oct; 12(1):140. PubMed ID: 22029856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma.
    Gauvreau GM; Hohlfeld JM; FitzGerald JM; Boulet LP; Cockcroft DW; Davis BE; Korn S; Kornmann O; Leigh R; Mayers I; Watz H; Grant SS; Jain M; Cabanski M; Pertel PE; Jones I; Lecot JR; Cao H; O'Byrne PM
    Eur Respir J; 2023 Mar; 61(3):. PubMed ID: 36822634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel inhaled phosphodiesterase 4 inhibitor (CHF6001) reduces the allergen challenge response in asthmatic patients.
    Singh D; Leaker B; Boyce M; Nandeuil MA; Collarini S; Mariotti F; Santoro D; Barnes PJ
    Pulm Pharmacol Ther; 2016 Oct; 40():1-6. PubMed ID: 27373438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.
    Hamilton AL; Watson RM; Wyile G; O'Byrne PM
    Thorax; 1997 Apr; 52(4):348-54. PubMed ID: 9196518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal GSK2245035, a Toll-like receptor 7 agonist, does not attenuate the allergen-induced asthmatic response in a randomized, double-blind, placebo-controlled experimental medicine study.
    Siddall H; Quint D; Pandya H; Powley W; Shabbir S; Hohlfeld JM; Singh D; Lee L
    PLoS One; 2020; 15(11):e0240964. PubMed ID: 33166307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of allergen-induced asthmatic response in smokers and non-smokers: effects of inhaled corticosteroids.
    Cahn A; Boyce M; Mistry S; Musani N; Rambaran C; Storey J; Ventresca P; Michel O
    Clin Exp Allergy; 2015 Oct; 45(10):1531-41. PubMed ID: 26251958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics.
    Paggiaro PL; Dente FL; Morelli MC; Bancalari L; Di Franco A; Giannini D; Vagaggini B; Bacci E; Fabbri LM; Giuntini C
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1447-51. PubMed ID: 8004297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of fluticasone and montelukast on allergen-induced asthma.
    Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
    Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.